GlassScriptPhysician profile
Colbi Michelle Smithton
NPI 1376538454
$2,481.97
in general payments reported to CMS, 2019-2025
36 companies · $149 in 2025
The $149 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $427 · 2020: $396 · 2021: $590 · 2022: $175 · 2023: $399 · 2024: $347 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $895.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $894.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $340.45 | 2019-2025 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Supernus Pharmaceuticals, INC. | $269.69 | 2021-2024 | Qelbree |
| Lilly USA, LLC | $213.99 | 2019-2024 | Mounjaro, Trulicity, Zepbound |
| Janssen Pharmaceuticals, INC | $171.04 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $146.99 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $142.59 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $136.58 | 2020-2021 | |
| Abbvie INC. | $130.55 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $96.77 | 2019-2023 | Xifaxan |
| Pfizer INC. | $94.40 | 2019-2023 | |
| Corium, LLC | $92.98 | 2023 | Azstarys |
| Exact Sciences Corporation | $49.23 | 2023 | Cologuard Collection Kit |
| Genentech USA, INC. | $44.51 | 2020-2021 | |
| Glaxosmithkline, LLC. | $43.53 | 2022-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Organon LLC | $42.50 | 2021-2023 | Nexplanon |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $39.18 | 2024-2025 | Dyanavel Xr |
| Bausch Health US, LLC | $38.67 | 2023-2024 | Aplenzin, Wellbutrin |
| Amgen INC. | $36.84 | 2021-2023 | Evenity, Prolia |
| Shire North American Group INC | $35.50 | 2019 | |
| Novo Nordisk INC | $35.36 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $34.19 | 2021 | |
| Idorsia Pharmaceuticals US INC | $28.83 | 2022-2023 | Quviviq |
| Veran Medical Technologies, INC. | $20.99 | 2020 | |
| Abbott Laboratories | $20.16 | 2021 | |
| Sumitomo Pharma America, INC. | $20.15 | 2025 | Gemtesa |
| Mylan Pharmaceuticals INC. | $18.04 | 2021 | |
| Genzyme Corporation | $17.62 | 2025 | |
| Agios Pharmaceuticals, INC. | $15.60 | 2025 | Pyrukynd |
| Phathom Pharmaceuticals, INC. | $15.29 | 2024 | Voquezna |
| Bardy Diagnostics, INC. | $14.86 | 2021 | |
| Currax Pharmaceuticals LLC | $13.06 | 2023 | Onzetra Xsail, Contrave |
| Alexion Pharmaceuticals, INC. | $12.88 | 2020 | |
| Allergan, INC. | $12.87 | 2020 | |
| Mission Pharmacal Company | $12.80 | 2019 | |
| Dermira, INC. | $12.49 | 2020 | |
| Nalpropion Pharmaceuticals LLC | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colbi Smithton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.